6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Original text

Rate this translation

Your feedback will be used to help improve Google Translate

Latest Press Releases

Time	Headline
12m ago	Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial
16m ago	Dürr : Alexandra Dambeck to become Dürr AG’s new CFO
17m ago	Advanced Drainage Systems Announces Fourth Quarter and Fiscal Year 2026 Results
18m ago	Wolters Kluwer shareholders approve all resolutions at the 2026 AGM
19m ago	Diversified Energy Provides Board of Director Update

About

435.80SEK-0.60 -0.14%

Closed • Updated at 10:59 GMT+00:00

Market Cap$16.06B

P/E Ratio171.02

Volume28.4K

Beta1.21

RSI59.96

Gross Margin44.93%

Health TechnologyPharmaceuticals: Major

Swedish Orphan Biovitrum Ab — investor relations, events, news, and company updates on 6ix.

Latest News

Bulletin from Sobi's Annual General Meeting (AGM)

Sobi Q1 2026 report: Strong execution and pipeline momentum

Invitation: Sobi's Q1 2026 report

Sobi Receives Health Canada Approval for EMPAVELI® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN

Sobi publishes Annual and Sustainability Report for 2025

Community Chat

Ask AI